Sandu Pharmaceuticals standalone net profit declines 38.24% in the September 2018 quarter
Sales decline 30.19% to Rs 12.21 crore
Net profit of Sandu Pharmaceuticals declined 38.24% to Rs 0.21 crore in the quarter ended September 2018 as against Rs 0.34 crore during the previous quarter ended September 2017. Sales declined 30.19% to Rs 12.21 crore in the quarter ended September 2018 as against Rs 17.49 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales12.2117.49 -30 OPM %5.574.69 -PBDT0.470.46 2 PBT0.310.34 -9 NP0.210.34 -38Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 19 2018 | 12:35 PM IST